Paul Kim

President Donald Trump on Monday signed a sweeping executive order aimed at drastically reducing prescription drug prices in the U.S. What Happened: The Trump administration wants to tie drug prices to the lowest amount paid in comparable foreign countries — a policy known as “most-favored-...

GMP Securities analyst Paul Kim recently made a 55 percent return on a Fitbit Inc (NYSE: FIT) short in a matter of months. The trade was such a home run that SumZero recently went back and highlighted Kim’s original rationale for the short. Kim’s main thesis for the short position...